These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29766941)

  • 21. Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort.
    Barsotti S; Dastmalchi M; Notarnicola A; Leclaire V; Dani L; Gheorghe K; Ekholm L; Bottai M; Tjärnlund A; Lundberg IE
    Semin Arthritis Rheum; 2020 Jun; 50(3):492-497. PubMed ID: 32024593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.
    Cavazzana I; Fredi M; Selmi C; Tincani A; Franceschini F
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):88-98. PubMed ID: 26514357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
    Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
    Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of idiopathic inflammatory myopathies with special reference to borderland between idiopathic inflammatory myopathies and muscular dystrophies.
    Khadilkar SV; Patil SG; Amin SN
    Neurol India; 2008; 56(3):356-62. PubMed ID: 18974564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and diagnostic tools in idiopathic inflammatory myopathies.
    Tsamis KI; Boutsoras C; Kaltsonoudis E; Pelechas E; Nikas IP; Simos YV; Voulgari PV; Sarmas I
    Crit Rev Clin Lab Sci; 2022 Jun; 59(4):219-240. PubMed ID: 34767470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of idiopathic inflammatory myopathies with novel myositis-specific autoantibodies.
    Rams A; Kosałka-Węgiel J; Kuszmiersz P; Matyja-Bednarczyk A; Polański S; Zaręba L; Bazan-Socha S
    Adv Clin Exp Med; 2021 Dec; 30(12):1239-1248. PubMed ID: 34610217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inflammatory myopathies: diagnosis and classifications].
    Dimitri D
    Presse Med; 2009; 38(7-8):1141-63. PubMed ID: 19282137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of 2017 classification criteria for adult and juvenile idiopathic inflammatory myopathies proposed by EULAR/ACR in Chinese patients.
    Zhang X; Yang X; Ji L; Zhang Z
    Int J Rheum Dis; 2019 Jul; 22(7):1278-1282. PubMed ID: 31124267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classification of idiopathic inflammatory myopathies: pathology perspectives.
    Tanboon J; Nishino I
    Curr Opin Neurol; 2019 Oct; 32(5):704-714. PubMed ID: 31369423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and classification of idiopathic inflammatory myopathies.
    Lundberg IE; Miller FW; Tjärnlund A; Bottai M
    J Intern Med; 2016 Jul; 280(1):39-51. PubMed ID: 27320359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
    Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
    BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G; Antonini G; Garibaldi M
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical course of idiopathic inflammatory myopathies: complications, survival and prognostic factors].
    Miró O; Laguno M; Alonso JR; Casademont J; Herrero C; Selva A; Urbano-Márquez A; Grau JM
    Med Clin (Barc); 1999 Apr; 112(14):521-6. PubMed ID: 10363237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sporadic Inclusion Body Myositis: A Clinicopathological Study.
    Challa S; Jakati S; Narla S; Uppin MS; Kannan MA; Jagarlapudi MKM
    Neurol India; 2021; 69(3):638-641. PubMed ID: 34169859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of new biomarkers of idiopathic inflammatory myopathy.
    Lu X; Peng Q; Wang G
    Clin Chim Acta; 2015 Apr; 444():117-25. PubMed ID: 25681646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification criteria for the idiopathic inflammatory myopathies.
    Targoff IN; Miller FW; Medsger TA; Oddis CV
    Curr Opin Rheumatol; 1997 Nov; 9(6):527-35. PubMed ID: 9375282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti-Melanoma Differentiation-Associated Protein 5 Positivity.
    So H; So J; Lam TT; Wong VT; Ho R; Li WL; Mok CC; Lau CS; Tam LS
    Arthritis Rheumatol; 2022 Sep; 74(9):1588-1592. PubMed ID: 35467787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Where are we moving in the classification of idiopathic inflammatory myopathies?
    Tanboon J; Uruha A; Stenzel W; Nishino I
    Curr Opin Neurol; 2020 Oct; 33(5):590-603. PubMed ID: 32852298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies.
    Honda M; Shimizu F; Sato R; Nakamori M
    J Neuromuscul Dis; 2024; 11(1):5-16. PubMed ID: 38143369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.